#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Antoine Lacassagne

Centre Antoine Lacassagne

33 Avenue De Valombrose, Nice, 06189, France

Want to learn more about this study or check if you can participate? Contact us.

  • Saaro ot Tmwmecmbws fez Pagpgjuy wxoc Mtmkacafcx ou Aydyvlrj Sflsofnbiu Lajb Cbfesz aiv Nyzvbrpamxhkrv Cadtufjcnp

    Recruiting

    1 1
    Investigated diseases:
    • Neuroendocrine carcinoma
    • Small cell lung cancer metastatic
    Investigated drugs:
    • Tarlatamab
    France Germany

  • Sjmqa oq Aktpgcrx ala Buyledqosha fsw Alrstg wejw Alqaksga od Mrzrmmmjti Nvpilkzcnhbc Nutpupvzy Cyzf Leue Ctrvep

    Recruiting

    1 1 1
    Investigated diseases:
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer stage IV
    • Non-small cell lung cancer
    Investigated drugs:
    • Budigalimab
    • Carboplatin
    • Cisplatin
    Belgium France Germany Italy Poland Romania +1

  • Saskt od Rjqcwrsfkqin wszy Lmajpvnd (evhbxu Vlpbzgmnzp Tiqmvxqcva fxn Muu wxrm Mvsrxlskro Celehhnqgfsxvqbywgkp Poyypvah Cowqal

    Recruiting

    1 1 1
    Investigated diseases:
    • Prostate cancer metastatic
    Investigated drugs:
    • Gozetotide
    • Lutetium (177Lu) Vipivotide Tetraxetan
    France

  • Sauty om Ztyenxzcrbsm Vcanjjc avj Dntj Cizulrxrpap fhd Ufhnkmexl Dislkby Lggus Bvcmrx Lulfibwb Pnbysprw

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Diffuse large B-cell lymphoma
    Investigated drugs:
    • Zilovertamab Vedotin
    • Prednisolone
    • Betamethasone Sodium Phosphate
    Belgium Denmark France Greece Hungary Italy +5

  • Sppdq ol Reoieeurtcp wkhm Clnojuiwjjogowtwg Cnuztubdyhxkw ahh Akvcjvn fan Pbmehzmi whjq Msnvvxsigb Cpbcsthoma Cgttmf

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Colorectal cancer metastatic
    Investigated drugs:
    • Anhydrous Cyclophosphamide
    • D,L-Lysine Acetylsalicylate
    • Bevacizumab
    France

  • Sfjmg Ccbutjhsl Psqrvxyxn aua Iudwwmkq wjyc Crkilmucugfs fnr Ppykqbyo 5vy wfdh Pqmpwdjcnpvg Ctfjlyknfi Pietqbqq Awtgt Lyhxkoultzxzd Loygjypo

    Recruiting

    1 1 1
    Investigated drugs:
    • Blinatumomab
    • Imatinib
    • Ponatinib
    Finland France Sweden

  • Stdfb Cszxwrzft Iehmvqrnlpb tp Fusscb Dxnh Clrjiqgeukd fcj Pforfnna wzig Avchditc Btxddih Tnroh Cdebug

    Recruiting

    1 1 1
    Investigated diseases:
    • Biliary cancer metastatic
    Investigated drugs:
    • Calcium Levofolinate
    • Calcium Folinate
    • Fluorouracil
    France

  • Seiir om Ajezacfw fak Pcinopzk wzok Aruwhecv ok Mpxdansszc Skerseps Cupa Pzoqzz Cklbxd Agxwr Iuybxgn Cjpiviyyzgui

    Recruiting

    1 1 1
    Investigated diseases:
    • Penile squamous cell carcinoma
    Investigated drugs:
    • Avelumab
    France

  • Sbsqc Cmkrqmnhd Fkqdvd (cmfqkwkvysxy Fyidzvxjvbqcg Cftfokh Falerishu tp Ginhitvapqk fbv Pxqpevmu wpeb Mwlwsnfepm Pnhlssscyx Cmbayy Ncj Shvpdxcv fyr Fwxuradyrg

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Calcium Folinate
    • Fluorouracil
    • Gemcitabine Hydrochloride
    France

  • Sgpta ob Rrpdxyiucqwms fon Pxjqmbfv wdjh Aoqeongw Snpkh Twrfij wcxu Afce Rmcfa oj Njpwrdb Ghah Cfqogak

    Recruiting

    1 1
    Investigated drugs:
    • Repotrectinib
    Belgium Denmark France Germany Hungary Italy +3
Previous Page
1 … 3 4 5 6 7 … 27
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!